EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

FuSViz—visualization and interpretation of structural variation using cancer genomics and transcriptomics data

Sen Zhao iD, Sigve Nakken iD, Daniel Vodak, Eivind Hovig iD

Nucleic Acids Research · 2025

DOI: 10.1093/nar/gkaf078 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Sen Zhao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Oslo University Hospital, 0424 Oslo, Norway. Hauptthemen laut MEDLINE: Neoplasms, Genomics, Software, Genomic Structural Variation. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Precision Diagnostics (InPred), Research Council of Norway, Oslo University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Structural variation (SV) is a frequent category of genetic alterations important for understanding cancer genome evolution and revealing key cancer driver events. With the development of high-throughput sequencing technologies, the ability to detect SVs of various sizes and types has improved, at both the DNA and RNA levels. However, SV calls are still prone to a considerable fraction of false positives, which necessitates visual inspection and manual curation as part of the quality control process. Identification of reliable and recurrent SVs in larger cohorts lends strength to revealing the driving roles of SVs in cancer development and to the discovery of potential diagnostic and prognostic biomarkers. Here, we present FuSViz, an application for visualization, interpretation, and prioritization of SVs. The tool provides multiple data view approaches in a user-friendly interface, allowing the investigation of prevalence and recurrence of SVs and relevant partner genes in a sample cohort. It integrates SV calls from DNA and RNA sequencing datasets to comprehensively illustrate the biological impact of SVs on the implicated genes and associated genomic regions. The functionality of FuSViz is intended for interrogation of both recurrent and private SVs, effectively assisting with pathogenicity evaluation and biomarker discovery in cancer sequencing projects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsGenomicsSoftwareGenomic Structural VariationTranscriptomeHumansHigh-Throughput Nucleotide SequencingGene Expression Profiling

Autor:innen und Institutionen

  • Department of Pathology, Oslo University Hospital, 0424 Oslo, Norway.
  • Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, 0424 Oslo, Norway.
  • Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0379 Oslo, Norway.
  • Center for Bioinformatics, Department of Informatics, University of Oslo, 0316 Oslo, Norway.

ORCID-Profile: Sen Zhao, Sigve Nakken, Eivind Hovig

Förderung

  • Precision Diagnostics (InPred)
  • Research Council of Norway
  • Oslo University Hospital

Zitieren

APA

Zhao, S., Nakken, S., Vodak, D., & Hovig, E. (2025). FuSViz—visualization and interpretation of structural variation using cancer genomics and transcriptomics data. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf078

Vancouver

Zhao S, Nakken S, Vodak D, Hovig E. FuSViz—visualization and interpretation of structural variation using cancer genomics and transcriptomics data. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf078

BibTeX
@article{Zhao2025,
  author = {Zhao, Sen and Nakken, Sigve and Vodak, Daniel and Hovig, Eivind},
  title = {FuSViz—visualization and interpretation of structural variation using cancer genomics and transcriptomics data},
  journal = {Nucleic Acids Research},
  year = {2025},
  doi = {10.1093/nar/gkaf078}
}
Kostenlos starten →